62
Participants
Start Date
May 23, 2023
Primary Completion Date
November 30, 2023
Study Completion Date
November 30, 2023
BVA-200
Blood samples collected for measurement with the BVA-100 will also be tested with the BVA-200. The BVA-200 uses whole blood collection cartridges which allow for a precise amount of blood to be measured without the need to first centrifuge and then pipette plasma aliquots. A small amount of whole blood from each sample will be set aside for BVA-200 use, while the remainder of the blood sample is used for BVA-100 measurement. The BVA-200 device was developed with the support of the Department of Defense through Phase I (W81XWH19C0048) and Phase II (W81XWH20C0025) SBIR contracts.
Daxor Corporation, Oak Ridge
Lead Sponsor
Stern Cardiovascular Foundation, Inc.
INDUSTRY
Oregon Health and Science University
OTHER
Daxor Corporation
INDUSTRY